CHLA researchers uncover mechanisms driving adult membranous nephropathy, which could potentially lead to novel treatments for pediatric chronic kidney disease.
A Children’s Hospital Los Angeles team developed the test, which is the first to precisely measure how much cerebrospinal fluid is flowing through a shunt.
The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.